Top Suppliers:I want be here
Related CAS#:
213819-48-8 1346598-22-8
65-22-5 1406-14-0
6138-79-0 127228-87-9
1406-02-6 929-73-7
65546-09-0 75752-15-7

213819-48-8

213819-48-8 structure
213819-48-8 structure
  • Name: Belotecan hydrochloride(CKD-602)
  • Chemical Name: Belotecan hydrochloride
  • CAS Number: 213819-48-8
  • Molecular Formula: C25H28ClN3O4
  • Molecular Weight: 469.96100
  • Catalog: Research Areas Cancer
  • Create Date: 2018-07-20 11:18:54
  • Modify Date: 2024-01-03 18:51:03
  • Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic and water-soluble camptothecin derivative.
Name Belotecan hydrochloride
Synonyms Belotecan HCl
Camtobell hydrochloride
CKD 602
Belotecan (hydrochloride)
Description Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic and water-soluble camptothecin derivative.
Related Catalog
Target

Top1
In Vitro Belotecan exerts a significant cytotoxic effect on YD-8, YD-9 and YD-38 cells in a time- and dose-dependent manner with IC50 values of 2.4, 0.18 and 0.05 μg/mL at 72 h following treatment. Belotecan induces apoptosis in these cell lines. Belotecan induces G2/M phase arrest in oral squamous cell cancer cells[1]. Belotecan shows a significant anticancer effect on glioma cells, with IC50 values of 9.07 nM for LN229, 14.57 nM for U251 MG, 29.13 nM for U343 MG, and 84.66 nM for U87 MG[2].
In Vivo Belotecan has a significant effect on intracerebral glioma growth, with animals having significantly smaller tumors than those in the control group[3].
Cell Assay The cells are treated with different concentrations (0.01, 0.1, 0.5, 1, 5 and 10 μg/mL) of belotecan for 24, 48 and 72 h. Control samples of each cell line are treated with medium only. Cell viability is measured using the MTS assay[1].
Animal Admin Mice: Nude mice with established U87MG glioma are treated with a dose of belotecan of 0 mg/kg (control group, injection with saline), 40 mg/kg (group A) or 60 mg/kg (group B). Thereafter, the dose is repeated once every 4 days for a total of four doses. Tumor volume is measured histologically and apoptosis is detected[1].
References

[1]. Kim YK, et al. Anticancer effects of CKD-602 (Camtobell®) via G2/M phase arrest in oral squamous cell carcinoma cell lines. Oncol Lett. 2015 Jan;9(1):136-142.

[2]. Kim YY, et al. CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell lines. Oncol Rep. 2009 Jun;21(6):1413-9.

[3]. Kim CY, et al. Antitumor activity of CKD-602, a camptothecin derivative, in a mouse glioma model. J Clin Neurosci. 2012 Feb;19(2):301-5.
Boiling Point 772.4ºC at 760mmHg
Molecular Formula C25H28ClN3O4
Molecular Weight 469.96100
Flash Point 420.9ºC
Exact Mass 469.17700
PSA 93.45000
LogP 3.81300
Vapour Pressure 4.21E-25mmHg at 25°C
Storage condition 2-8℃
78287-26-0 structure

78287-26-0
75-31-0 structure

75-31-0
77-78-1 structure

77-78-1

~46%

213819-48-8 structure

213819-48-8
Literature: Ahn, Soon Kil; Choi, Nam Song; Jeong, Byeong Seon; Kim, Kye Kwang; Journ, Duck Jin; Kim, Joon Kyum; Lee, Sang Joon; Kim, Jung Woo; Hong, Chung Il; Jew, Sang-sup Journal of Heterocyclic Chemistry, 2000 , vol. 37, # 5 p. 1141 - 1144
7689-03-4 structure

7689-03-4

~%

213819-48-8 structure

213819-48-8
Literature: Journal of Heterocyclic Chemistry, , vol. 37, # 5 p. 1141 - 1144
Precursor  4

DownStream  0


Chemsrc provides CAS#:213819-48-8 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 213819-48-8 | Chemsrc address: https://www.chemsrc.com/en/baike/37173.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved